Your browser doesn't support javascript.
loading
Beyond the Surviving Sepsis Campaign Guidelines: a systematic review of interventions affecting mortality in sepsis.
Sartini, Chiara; Landoni, Giovanni; Belletti, Alessandro; Kotani, Yuki; Maimeri, Nicolò; Umbrello, Michele; Yavorovskiy, Andrey; Jabaudon, Matthieu.
Afiliação
  • Sartini C; Neurosurgical Intensive Care Unit, ASST Santi Paolo e Carlo - San Carlo Borromeo Hospital, Milan, Italy.
  • Landoni G; Vita-Salute San Raffaele University, Milan, Italy - landoni.giovanni@hsr.it.
  • Belletti A; Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Kotani Y; Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Maimeri N; Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan.
  • Umbrello M; Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Yavorovskiy A; Section of Resuscitation and Anesthesia, Ospedale Nuovo di Legnano, ASST Ovest Milanese, Legnano, Milan, Italy.
  • Jabaudon M; Department of Anesthesiology and Intensive Care, I.M. Sechenov First Moscow State Medical University of the Russian Ministry of Health, Moscow, Russia.
Panminerva Med ; 66(1): 55-62, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38093626
ABSTRACT

INTRODUCTION:

Sepsis-related mortality is decreasing over time after the introduction of "Surviving Sepsis Campaign" Guidelines in 2004. The last Guidelines version collects 93 recommendations, but several interventions supported by randomized evidence of mortality reduction are not included. EVIDENCE ACQUISITION We performed a systematic review of all randomized controlled trials reporting a statistically significant mortality reduction in septic patients and compared the identified studies to the Surviving Sepsis Campaign Guidelines 2021 to highlight discrepancies. EVIDENCE

SYNTHESIS:

We identified 83 randomized controlled trials (58 interventions) influencing mortality in sepsis. Only 9/58 of these interventions were included in the Guidelines lactate measurement and lactate-guided hemodynamic management, procalcitonin-guided antibiotics discontinuation, balanced crystalloids as first choice fluids, albumin infusion, avoidance of starches, noradrenaline as first line vasopressor, vasopressin as an adjunctive vasopressor to noradrenaline, neuromuscular blocking agents in moderate-severe sepsis-associated acute respiratory distress syndrome, and corticosteroids use. Only 11/93 Guidelines recommendations were supported by randomized evidence with mortality difference. Five of the interventions with survival benefit in literature (vitamin C, terlipressin, polymyxin B, liberal transfusion strategy and immunoglobulins) were recommended to avoid in the Guidelines, while 44 interventions were not mentioned, including three interventions (esmolol, omega 3, and external warming) with at least two randomized controlled trials with a documented survival benefit.

CONCLUSIONS:

Several discrepancies exist between the randomized controlled trials with mortality difference in septic patients and the latest Surviving Sepsis Campaign Guidelines. This systematic review can be of help for improving future guidelines and may guide research on specific promising topics.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Choque Séptico / Sepse Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Choque Séptico / Sepse Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article